Pathogenic peculiarities of post-traumatic knee osteoarthrosis: analysis of diagnostic and therapeutic strategies (review)

Bibliography:
1. Road map of the national health service in the Russian Federation till 2020. http://federalbook.ru/files/FSZ/so-derghanie/Tom%2012/1-9. pdf (March 06, 2020). Russian (Концепция развития системы здравоохранения в РФ до 2020 г. http://federalbook.ru/files/FSZ/soderghanie/Tom%20 12/1-9. pdf (20.02.2020).
2. Aleksanin SS, Gudz YuV. The concept of organization and technology of specialized traumatology care provision for emergency victims in the hospital of the Ministry of Emergency Situations of Russia. Systemic analysis and management in biomedical systems 2018; 17 (1): 127-136).
3. Tyurin AV, Davletshin RA, Farkhutdinov RR, Zaripova RM, et al. Peculiarities of intercellular substance metabolism of patients with osteoarthritis and connective tissue dysplasia. Clinical physician 2014; (2): 33-38.
4. Bozic KJ, Cramer В, Albert TJ. Medicare and the orthopaedic surgeon: challenges in providing, financing, and accessing musculoskeletal care for the elderly. Bone Joint Surg Am 2010; 92: 1568-1574.
5. DubikovAl, Kabalyk MA, et al. Cartillage microcrystallization phenomenon in coxarthrosis and avascular necrosis of femoral head. Rheumatology Science and Practice 2012; 50 (5): 37-41.
6. Bellido М, Lugo L, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther 2010; 12 (4): R152. doi: 10.1186/ar3103.
7. Bouvard B, Abed E, et al. Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 2014; 16 (5): 459. doi: 10.1186/s13075-014-0459-3.
8. Sazonova NV. Arrangement of the specialized orthopedic care for patients with hip and knee osteoarthrosis: DSc diss. Kurgan, 2009; 320 p.
9. Cheng Т, Zhang L, et al. The potential protective effects of calcitonin involved in coordinating chondrocyte response, extracellular matrix, and subchondral trabecular bone in experimental osteoarthritis. Connect Tissue Res 2013; 54 (2): 139-146.
10. Huh JE, Seo DM, et al. Biphasic positive effect of formononetin on metabolic activity of human normal and osteoarthritic subchondral osteoblasts. Int Immunopharmacol 2010; 10 (4): 500-507.
11. Shostak NA. Osteoarthrosis: issues of diagnostics and treatment. Russian medical journal Rheumatology 2014; (4): 278-281.
12. Neogi Т. The Epidemiology and Impact of Pain in Osteoarthritis. Osteoarthritis Cartilage 2013; 21 (9): 1145-1153.
13. Bragiva SV. Optimization of gonarthrosis treatment in outpatient practice of orthopedist: PhD diss. Arkhangelsk, 2012; 220 p.
14 Viktorov АР. Actual Safety issues of Medicamental Treatment of Osteoarthritis in Elderly Patients. Liki Ukrainy 2011; 4 (150): 122-126.
15. Alekseenko EU, Govorin AV. Clinical features of the connective tissue dysplasia in patients with osteoarthrosis. Cuban medical scientific bulletin 2009; 6 (111): 7-9.
16. Svetlova MS. Theraflex for treating early gonarthrosis. Russian Medical Journal 2010; (9): 592-594.
17. Chappie CM, Nicholson Н, Baxter GD, Abbott JH. Patient characteristics that predict progression of knee osteoarthritis: a systematic review of prognostic studies. Arthritis Care Res (Hoboken) 2011; 63 (8): 25-35.
18. Mironov SP, Es'kin NA, Andreeva TM. Specialized traumatologic and orthopaedic care for outpatients with injuries and bone-muscular diseases. N.N. Priorov Journal of Traumatology and Orthopedics 2010; (1): 3-8.
19. Ben DP, Appl J, et al. The effects of osteoarthritis and age on skeletal muscle strength. Physiol 2013; 115: 1443-1449.
20. Moon PM, Beier F. Novel insights into osteoarthritis joint pathology from studies in mice. Curr. Rheumatol. Rep 2015; 17: 50. Doi: 10.1007/sl 1926-015-0524-1
21. Wang Y, Teichtahl AJ, et al. Osteoarthritis year in review 2015: imaging. Osteoarthritis Cartilage 2016; 24 (1): 49-57.
22. Zhang M, Wang J. Epigenetics and osteoarthritis. Genes Dis 2015; 2(1): 69-75.
23. Tiurin AV, Khusainova Rl, Davletshin RA, Khusnutdinova EK. Modern views on the pathogenesis and genetics of osteoarthritis. Medical genetics 2013; 12 (3): 3-10.
24. Filippenko VA, Leonteva FS, Morozenko DV, Korzh VI. Laboratory diagnostic markers at evaluating the condition of osteoarthrosis patients requiring replacement of large joints (literature review). Orthopedics, Traumatology and Prosthetics 2013; (2): 122-126.
25. Silvestri Е, Corazza A, Molfetta L, Garlaschi G. Metabolic bone changes in osteoarthritis: the role of imaging and pathogenetic interpretation. Biol Regul Homeost Agents 2015; 29 (3): 737-743.
26. Nikolaeva SS, Roscshina AA, Kim Zohn Chkhol, et al. Specifics of certain biochemical and moisture exchange features of human arthrodial cartilage. Bulletin of Experimental Biology and Medicine 2002; 133 (5): 559-563.
27. Belova SV, Gladkova EV, Ulyanov VYu, Zubavlenko RA, et al. The condition of cellular immunity in patients with osteoarthrosis before and after endoprosthesis implantation. In: VII International symposium «Interaction of the nervous and immune systems in health and disease». May 27-31, 2019, Saint-Petersburg: 62-63.
28. Ishijima М, Kaneko Н, Kaneko К. The evolving role of biomarkers for osteoarthritis. Ther Adv Musculoskelet Dis 2014; 6(4): 144-153.
29. Allen KD, Bosworth HB, Brock DS, Chapman JG. Patient and provider interventions for managing osteoarthritis in primary care: Protocols for two randomized controlled trials. ВМС Musculoskelet Disord 2012; 13 (1): 60-65.
30. Felson DT Osteoarthritis: Virtual joint replacement as an outcome measure in OA. Nat Rev Rheumatol 2012; 8 (4): 187-188.
31. Popova LA, Sazonova NV. Structural characteristic of osteoarthrosis of lower extremities in Kurgan region inhabitants employed in different fields. Traumatology and orthopedics of Russia 2009; 1 (51): 107-111.
32. Hoch JM, Mattacola CG, Medina McKeon JM, Howard JS, et al. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 2011; 19 (12): 1396-1404.
33. van Spil WE, Jansen NW, et al. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage 2012; 20 (7): 745-754.
34. van Spil WE, Kloppenburg M. et al. Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK. Osteoarthritis Cartilage 2012; 20 (11): 1278-1285.
35. Kumm J, Tamm A, Lintrop M, Tamm A. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects. Rheumatol Int 2013; 33 (4): 903-911.
36. Nepple JJ, Thomason KM, An TW, Harris-Hayes M, et al. What is the utility of biomarkers for assessing the pathophysiology of hip osteoarthritis? A systematic review. Clin Orthop Relat Res 2015; 473 (5): 1683-1701.
37. Hosnijeh FS, Runhaar J, van Meurs JB, Bierma-Zeinstra SM. Biomarkers for osteoarthritis: Can they be used for risk assessment: A systematic review. Maturitas 2015; 82 (1): 36-49.
38. Gelber AC. Knee pain and osteoarthritis: lessons learned and lessons to be learned. Ann Intern Med 2015; 155 (11): 786-787.
39. Stogov MV, Ovchinnikov EN. Laboratory tests in preclinical diagnosis of osteoarthrosis. An analytical review. Genij Ortopedii 2016; (1): 96-103.
40. Valdes AM, Meulenbelt I, Chassaing E, et al. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Osteoarthritis Cartilage 2014; 22 (5): 683-689.
41. Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol 2013; 9 (7): 400-410.
42. Attur M, Statnikov A, Samuels J, Li Z, Alekseyenko AV, et al. Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis. Osteoarthritis Cartilage 2015; 23 (11): 1915-1924.
43. Imamura M, Ezquerro F, Marcon Alfieri F, Vilas Boas L, et al. Serum levels of proinflammatory cytokines in painful knee osteoarthritis and sensitization. Int J Inflam 2015; 329792: 8p.
44. Wang M, Shen J, Jin H, Im HJ. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann NYAcad Sci 2013; 1240 (12): 61-69.
45. Karyakina EV, Norkin IA, Gladkova EV, et al. Structural and functional characteristics of bone tissue and blood cytokines in health and disease of the joints. Russian Journal of Physiology 2014; 100 (2): 238-247.
46. Daghestani HN, Kraus VB. Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartilage 2015; 23 (11): 1890-1896.
47. Kuznetsova El, Chegurov OK, Kamshilov BV, et al. Functional-metabolic state of neutrophilic phagocytes in patients with articular diseases before performing primary and revision arthroplasty. Genij Ortopedii 2012; 4: 79-82
48. Chepeleva MV, Shved NS. Immunological special features of large jont osteoarthrosis of different etiology. Genij Ortopedii 2012; 2: 107-111.
49. Udartsev EU. Morphohistochemical aspects of the conservative treatment of patients with posttraumatic osteoarthrosis of major joints of lower limbs. Fundamental Research 2011; 6: 182-187.
50. Baragi VM, Becher G, Bendele AM, Biesinger R, et al. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum 2009; 60 (7): 2008-2018.